Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oncolytics Biotech Inc 804 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 CAN

P: 403-670-7377 F: 403-283-0858

Description:

Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

Key Statistics

Overview:

Market Capitalization, $K 62,245
Shares Outstanding, K 57,634
Annual Sales, $ 0 K
Annual Net Income, $ -20,990 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,350 K
60-Month Beta 2.32
% of Insider Shareholders 0.10%
% of Institutional Shareholders 2.10%
Float, K 57,576
% Float 99.90%
Short Volume Ratio 0.35

Growth:

1-Year Return -63.04%
3-Year Return -34.88%
5-Year Return -74.16%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 58.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 05/05/22
Next Earnings Date N/A
Earnings Per Share ttm -0.38
EPS Growth vs. Prev Qtr 18.18%
EPS Growth vs. Prev Year 10.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-19 on 05/25/18

ONCY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -66.47%
Return-on-Assets % -53.50%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.18
Book Value/Share 0.48
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar